Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation
Company Logo

Destroying Cancer at the Speed of Light®

Clinical Study Underway (75 of 100 Patients Treated)
Expected to complete enrollment in 2025
Expected to complete study at the end of 2026


Bullboard - Investor Discussion Forum Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  TLTFF

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called... see more

TSXV:TLT - Post Discussion

Theralase Technologies Inc. > Friends of Cancer lists all BTD
View:
Post by Infinity on Jan 12, 2023 4:51pm

Friends of Cancer lists all BTD

This link below lists up to date applications for BTD along with results from FDA  that you can down load.  Theralase is still not there as of today..


https://friendsofcancerresearch.org/breakthrough-therapies/?_sf_s=photo%20dynamic&_sft_therapy_category=cancer+cardiovascular&_sfm_date_year=2022-%2B-2023&_sft_fda_status=designation-granted+designation-rescinded+fda-approval
Comment by plantrader on Jan 12, 2023 4:56pm
Infinity, I don't think it lists applications. The FDA site says applications are confidential, not disclosed at all. I believe that search will only show BTD designations that have already been disclosed.
Comment by DJDawg on Jan 12, 2023 7:05pm
Yes. It shows approved but not applied. One small nugget of interest: "As of August 31, 2021, the FDA has approved 251* breakthrough therapy designated products and lists that there have been 1182 total requests for the designation with 458** designations granted." So around 40% of applications for BTD are approved as BTD.
Comment by gojotv! on Jan 13, 2023 12:40am
Yes, and when I see some of the treatments that have been approved, I'd say our chances of getting BTD, and even AA are excellent! The results speak for themselves... GLTA patient investors!  
Comment by Infinity on Jan 13, 2023 3:42am
Plantrader,  Yes, I agree, this is not from FDA.  There is nothing confidential about this web page and it pertains only to cancer treatments and not all other BTD applications.  However, it gives a pretty clear picture of BTD applications and approval ratios when you down load the stats.
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.


Connect with V.TLT



Investor Presentation

View the Presentation

FACT SHEET

View the Presentation

The Watchlist

The Watchlist
{{currentVideo.videoCaption}}
< Previous Video {{moreVideoText}} Next Video >

Investment Opportunity

The Road to Saving Lives: Clinical Study Underway

  • Clinical Study with 75 of 100 Patients Treated (Enrollment to be completed in 2025, with study completed by end of 2026)
     
  • Ground Floor Investment Opportunity in Multi-Billion Dollar Industry
     
  • Best-in-class treatment for NMIBC (according to interim clinical data)
     
  • NMIBC (Non-Muscle-Invasive Bladder Cancer)
     

Facebook

Contact Us

Address:
41 Hollinger Road
Toronto, ON M4B 3G4
Canada

Toll Free:
1-866-THE-LASE (843-5273)
Local Phone:
416-699-LASE (5273)

Email:
info@theralase.com

Fax:
416-699-5250